Stanford Health Care
About Stanford Clinical LaboratoryLicensureContact Us

Home
Test Directory

Test Requisitions Specimen Collection
Critical Values
Administrative Department
Clinical DepartmentsDepartment of PathologyEsoteric DepartmentsFeatured Services



Esoteric Departments: All Available Tests

RBC Special Studies View Department Homepage

TESTS:
Select a test to view Test Description & Clinical Indications
TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions
ADENOSINE DEAMINASE (ADA), BLOOD, QUANTITATIVE ADAQ
EMA (EOSIN-5-MALEIMIDE) BY FLOW CYTOMETRY EMA
G6PD FEMALE CARRIER STATUS PANEL LABG6PDF
GLUCOSE-6-PHOSPHATE DEHYDROGENASE, QUANTITATIVE, WHOLE BLOOD G6PDQT
HEMOGLOBIN F QUANTITATIVE HGBFQ
HEMOGLOBIN QUANTITATION / FRACTIONATION BY CAPILLARY ZONE ELECTROPHORESIS HGBQ
HEMOGLOBIN S QUANTITATIVE HGBSQ
OSMOTIC FRAGILITY, RBC OF
PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) QUANTITATIVE PNPQ
RBC ENZYME PANEL RBCENZ

Back To Top

Biochemical Genetics View Department Homepage

TESTS:
Select a test to view Test Description & Clinical Indications
TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions
ACYLCARNITINE PROFILE, QUANTITATIVE ACYLP
AMINO ACIDS, BLOOD SPOT AABS
AMINO ACIDS, QUANTITATIVE, CSF AACSF
AMINO ACIDS, QUANTITATIVE, PLASMA AAP
AMINO ACIDS, QUANTITATIVE, URINE AAUR
BIOTINIDASE BTDASE
BRANCHED CHAIN AMINO ACIDS BCAA
CARNITINE, FREE AND TOTAL, PLASMA/SERUM CARN
CARNITINE, FREE AND TOTAL, URINE UCARN
METHYLMALONIC ACID, SERUM MMAS
MUCOPOLYSACCHARIDES, TLC, URINE MPSTLC
MUCOPOLYSACCHARIDES, URINE, QUANTITATIVE MPSQNT
OLIGOSACCHARIDES, TLC, URINE OSTLC
ORGANIC ACIDS, QUALITATIVE, URINE UORG
OROTIC ACID, URINE UOROT
PHENYLALANINE AND TYROSINE PHATYR

Back To Top

Cytogenetics/FISH View Department Homepage

TESTS:
Select a test to view Test Description & Clinical Indications
TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions
12P COPY NUMBER FISH 12Pcn
13Q, FISH CGFi 13Q
1P/19Q DELETIONS IN OLIGODENDROGLIOMA FISH GLIOMA
4P- SYNDROME (WOLF-HIRSCHHORN SYNDROME), 4P16.3 CGF MCDEL
5P- SYNDROME (CRI DU CHAT SYNDROME), 5P15.2 CGF MCDEL
5Q, FISH CGFi 5Q
7Q, FISH CGFi 7Q
ALK GENE REARRANGEMENT FISH ALK
ALK, FISH CGFi ALK
ANGELMAN SYNDROME (AS), 15Q11.2 (D15S10 DELETION) CGF ANGLM
ARRAY COMPARATIVE GENOMIC HYBRIDIZATION (ACGH) CGH GEN
BCL2 GENE REARRANGEMENT (CG FISH) CGFi BCL2
BCL2 GENE REARRANGEMENT IN FOLLICULAR LYMPHOMA (FISH BCL2 ) FISH BCL2
BCL6, FISH CGFi BCL6
BCR/ABL GENE FUSION IN CML AND ALL, T(9;22)(Q34;Q11.2) CGFi BCR
BRAF GENE REARRANGEMENT FISH BRAF
CCND1 GENE REARRANGEMENT (FFPE) FISH CCND1
CCND1/IGH GENE FUSION IN MANTLE CELL LYMPHOMA, T(11;14)(Q13;Q32) CGFi MCL
CENTROMERE PROBES (CROSS SEX TRANSPLANT; ANAUPLOIDY) CGFi ENUM
CHROM. #1 COPY NUMBER CGFi 1Q1P
CHROMOSOME SPECIFIC SUBTELOMERIC PROBES CGF MAR
CLL PANEL (+12, 11Q AND 13Q DELETION, 17P DELETION) [PERIPHERAL BLOOD PREFERRED] CGFi CLL
CRLF2, FISH CGFi CRLF2
CYTOGENETIC STUDY - AMNIOTIC FLUID CG AMNIO
CYTOGENETIC STUDY, BLOOD (CANCER DX.) CG BLD NEO
CYTOGENETIC STUDY, BLOOD, HIGH RESOLUTION CG HI RES
CYTOGENETIC STUDY, BLOOD, ROUTINE / PERCUTANEOUS UMBILICAL BLOOD SAMPLING (PUBS) CG BLOOD
CYTOGENETIC STUDY, BONE MARROW CG BONE MRW
CYTOGENETIC STUDY, CHORIONIC VILLI CG CVS
CYTOGENETIC STUDY, CHROMOSOME BREAKAGE FOR ATAXIA TELANGIECTASIA CG ATAXIA
CYTOGENETIC STUDY, CHROMOSOME BREAKAGE FOR FANCONI ANEMIA CG FANCONI
CYTOGENETIC STUDY, TISSUE, POC CG TISS POC
CYTOGENETIC STUDY, TISSUE, SKIN/OTHER CG TISS SKIN
CYTOGENETIC STUDY, TUMOR CG TUMOR
DIGEORGE SEQUENCE/VELOCARDIOFACIAL SYNDROME (VCF), 22Q11.2 (TUPLE1 DELETION) AND DISTAL 22Q13.3 DELETION (ARSA) CGF VCF
EGFR GENE AMPLIFICATION FISH EGFR
ETV6 GENE REARRANGEMENT FISH ETV6
ETV6, FISH CGFi ETV6
ETV6/RUNX1, FISH CGFi TEL
EWSR1 GENE REARRANGEMENT FISH EWSR1
FGFR1 GENE REARRANGEMENT CGFi FGFR1
FISH CHIC 2; DELETION (OR FIP1L1/PDGFRA FUSION) IN HES AND SMCD CGFi CHIC2
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) TESTING, PRENATAL PANEL CGF PRENAT
FOXO1 GENE REARRANGEMENT IN ALVEOLAR RHABDOMYOSARCOMA FISH FOXO1
FOXO1, FISH CGFi FOXO1
FUS GENE REARRANGEMENT FISH FUS
HER2 AMPLIFICATION BY FISH FISH HER2
HER2 GENE AMPLIFICATION, NON-BREAST FISH HER2nb
IGH GENE REARRANGEMENT CGFi IGH
IGH/BCL2, FISH CGFi FCL
IGH/FGFR3, FISH CGFi t(4;14)
IGH/MAF, FISH CGFi t(14;16)
INV(16) FISH CGFi inv(16)
KRAS GENE AMPLIFICATION FISH KRAS
MAML2 GENE REARRANGEMENT FISH MAML2
MAR/DEL 1-3, FISH CGF MAR
MDM2 GENE AMPLIFICATION FISH MDM2
MDS PANEL, FISH CGFi MDSpan
MET GENE AMPLIFICATION FISH METamp
MILLER-DIEKER SYNDROME (MDS), 17P13.3 (LIS1 DELETION) CGF MDK
MLL GENE REARRANGEMENT, 11Q23, IN AML AND ALL CGFi MLL
MYB GENE REARRANGEMENT FISH MYB
MYC GENE REARRANGEMENT IN BURKITT, OTHER LYMPHOMA FISH MYC
MYC, FISH CGFi cMYC
MYELOMA PANEL, FISH CGFi MMpan
P53, FISH CGFi P53
PDGFRB GENE REARRANGEMENT CGFi PDGRFB
PLAG1 GENE REARRANGEMENT FISH PLAG1
PML/RARA GENE FUSION IN APL, T(15;17)(Q22;Q21) CGFi APL
PRADER-WILLI SYNDROME (PWS), 15Q11.2 (SNRPN DELETION) CGF PWS
PRENATAL FISH FOR TRISOMIES 13, 18 AND 21, X AND Y CHROMOSOMES (5-10 ML DIRECT AMNIOTIC FLUID) CGF PRENAT
PRKACA GENE REARRANGEMENT FISH PRKACA
ROS1 GENE REARRANGEMENT FISH ROS1
SMITH-MAGENIS SYNDROME (SMS), 17P11.2 (FL1 DELETION) CGF SMS
SS18 (SYT) GENE REARRANGEMENT FISH SS18
SUBTELOMERIC FISH STUDIES FOR CRYPTIC REARRANGEMENTS CGF SUBTL
T(8;21), FISH CGFi t(8;21)
TFE3 GENE REARRANGEMENT FISH TFE3
TRISOMY 8 CGFi ENUM
UROVYSION FLUORESCENCE IN SITU HYBRIDIZATION (FISH) SCREENING RECURRENT BLADDER CANCER CGFi UROV
WHOLE CHROMOSOME PAINTS (TO IDENTIFY UNKNOWN REARRANGEMENTS/MARKERS) CGF WCPan
WILLIAMS SYNDROME (WS), 7Q11.23 (WSCR DELETION) CGF WMS
X-LINKED ICHTHYOSIS, XP22.3 (STEROID SULFATASE DELETION) CGF MCDEL

Back To Top

Virology View Department Homepage

TESTS:
Select a test to view Test Description & Clinical Indications
TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions
ADENOVIRUS QUANTITATIVE PCR, PLASMA ORDER ADVQT
BK VIRUS DNA PCR PLASMA, QUANTITATIVE BKVPC
BK VIRUS DNA PCR URINE, QUANTITATIVE BKVPCU
CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (GC), NUCLIEC ACID AMPLIFICATION TESTING (NAAT) CLGC3
CYTOMEGALOVIRUS QUANTITATIVE (CMV VIRAL LOAD) PCR CMVQT
CYTOMEGALOVIRUS(CMV) DNA, QUALITATIVE PCR, NON-PLASMA CMVQL
EPSTEIN BARR VIRUS (EBV) QUANTITATIVE PCR, PLASMA EBVQP
HEPATITIS B PCR QUANTITATIVE, SERUM HBPCR
HEPATITIS C VIRUS (HCV) RNA, QUANTITATIVE PCR, SERUM, WITH REFLEX TO GENOTYPING HCVPCX
HHV-6 QUANTITATIVE PCR, PLASMA ORDER HHV6QT
HIV-1 ANTIVIRAL RESISTANCE TESTING - INTEGRASE AVIN
HIV-1 ANTIVIRAL RESISTANCE TESTING, PROTEASE AND REVERSE-TRANSCRIPTASE, PLASMA AVRT
HIV-1 RNA, QUANTITATIVE PCR, PLASMA HIVPCR
HPV 16/18 TYPING HPVPCR
HPV 6/11 TYPING HPV6PC
HUMAN PAPILLOMAVIRUS VIRUS (HPV), NUCLIEC ACID AMPLIFICATION TESTING (NAAT) HPVHR3

Back To Top

Special Chemistry View Department Homepage

TESTS:
Select a test to view Test Description & Clinical Indications
TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions
SALIVARY CORTISOL SALCOR

Back To Top

Molecular Genetic Pathology View Department Homepage

TESTS:
Select a test to view Test Description & Clinical Indications
TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions
A/HYPOCHONDROPLASIA, BLOOD CHON
A/HYPOCHONDROPLASIA, NON-BLOOD FCHON
ALPHA THALASSEMIA, BLOOD ATHAL
ALPHA THALASSEMIA, NON-BLOOD FATHAL
AML PROGNOSIS ASSAY, BLOOD AMLP
AML PROGNOSIS ASSAY, NON-BLOOD BMAML
B-CELL CLONALITY BY PCR ,BLOOD BCLON
B-CELL CLONALITY, NON-BLOOD BMBCLO
BCR-ABL KINASE DOMAIN MUTATION ANALYSIS, BLOOD BCRKDM
BCR-ABL KINASE DOMAIN MUTATION ANALYSIS, NON-BLOOD NBCRKDM
BCR-ABL, BLOOD BCRQT
BCR-ABL, NON-BLOOD BMBCRQ
BETA THALASSEMIA SEQUENCING, BLOOD BTHSQ
BETA THALASSEMIA SEQUENCING, NON-BLOOD FBTHSQ
BIOTINIDASE SEQUENCING ASSAY BIOSA
BRAF, BLOOD BRAF
BRAF, NON-BLOOD NBRAF
CALRETICULIN MUTATION DETECTION, BLOOD CALR
CALRETICULIN MUTATION DETECTION, NON-BLOOD NCALR
CDH1 BY SEQUENCING (FAMILIAL GASTRIC CANCER) CDH1
CDH1 MLPA, BLOOD CDMLPA
CEBPA, BLOOD CEBPA
CEBPA, NON-BLOOD BMCEBP
CF POLY-T ANALYSIS, BLOOD CFPT
CF POLY-T ANALYSIS, NON-BLOOD NCFPT
CFTR DELETION/DUPLICATION ANALYSIS BY MLPA CFMLPA
CFTR SCREEN BY SEQUENCING CFSS
CONNEXIN 26 SEQUENCING, BLOOD CX26S
CONNEXIN 26 SEQUENCING, NON-BLOOD FCX26S
CONNEXIN 30, BLOOD CX30
CONNEXIN 30, NON-BLOOD NCX30
CYSTIC FIBROSIS DIAGNOSTIC SEQUENCING ASSAY, BLOOD CFDS
CYSTIC FIBROSIS DIAGNOSTIC SEQUENCING ASSAY, NON-BLOOD NCFDS
CYSTIC FIBROSIS MUTATION STUDY (CF), BLOOD CF32
CYSTIC FIBROSIS MUTATION STUDY (CF), NON BLOOD NCF32
DUCHENNE AND BECKER MUSCULAR DYSTROPHIES BY MLPA DBMLPA
EGFR, BLOOD EGFR
EGFR, NON-BLOOD NEGFR
FACTOR V LEIDEN, BLOOD LEID
FGFR1 CRANIOSYNOSTOSIS, BLOOD FGFR1
FGFR1 CRANIOSYNOSTOSIS, NON-BLOOD FFGFR1
FGFR2 CRANIOSYNOSTOSIS, BLOOD FGFR2
FGFR2 CRANIOSYNOSTOSIS, NON-BLOOD FFGFR2
FGFR3 MUENKE, BLOOD FGFR3
FGFR3 MUENKE, NON-BLOOD FFGFR3
FRAGILE X FRAGX
HEMOCHROMATOSIS GENOTYPING ASSAY HCHGA
HUNTINGTON'S DISEASE ANALYSIS BY PCR HUNT
IDH1 AND IDH2 MUTATION ANALYSIS LABIDH
JANUS KINASE 2 V617F MUTATION, BLOOD JAK2
JANUS KINASE 2 V617F MUTATION, NON-BLOOD NJAK2
KIT D816V MUTATION BY AS-PCR, BLOOD D816V
KIT D816V MUTATION BY AS-PCR, NON-BLOOD ND816V
KIT SEQUENCING (EXONS 8 AND 17), BLOOD CKITMU
KIT SEQUENCING (EXONS 8 AND 17), NON-BLOOD NCKIT
KRAS / NRAS MUTATION ANALYSIS RAS
MATERNAL CELL CONTAMINATION, FETAL SAMPLE FMCC
MATERNAL CELL CONTAMINATION, MATERNAL SAMPLE MCC
MGMT PROMOTER METHYLATION, BLOOD MGMTB
MGMT PROMOTER METHYLATION, NON-BLOOD MGMT
MICROSATELLITE INSTABILITY TMSI
MYD88 MUTATION ANALYSIS, BLOOD MYD88
MYD88 MUTATION ANALYSIS, NON BLOOD NMYD88
MYELOID NEXT GENERATION SEQUENCING ASSAY, BLOOD LABMYEL
MYELOID NEXT GENERATION SEQUENCING ASSAY, NON-BLOOD LABNMYEL
PENDRED SYNDROME, BLOOD PDS
PENDRED SYNDROME, NON-BLOOD NPDS
PML/RARA, QUANTITATIVE, BLOOD T1517
PML/RARA, QUANTITATIVE, NON-BLOOD BM1517
PRADER-WILLI SYNDROME PWS
PROTHROMBIN-20210A MUTATION, BLOOD P20210
SF3B1 BY SEQUENCING, BLOOD SF3B1
SF3B1 BY SEQUENCING, NON-BLOOD NSF3B1
STANFORD SOLID TUMOR ACTIONABLE MUTATION PANEL STAMP
T-CELL CLONALITY BY PCR REFLEX TO TCR-BETA (TCRB) REARRANGEMENTS, BLOOD TCLON
T-CELL CLONALITY BY PCR REFLEX TO TCR-BETA (TCRB) REARRANGEMENTS, NON-BLOOD BMTCLO
VH HYPERMUTATION, BLOOD VHHA
VH HYPERMUTATION, NON-BLOOD NVHHA

Back To Top

Special Coagulation View Department Homepage

TESTS:
Select a test to view Test Description & Clinical Indications
TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions
UNFRACTIONATED HEPARIN ACTIVITY BY ANTI-Xa ACTIVITY HEPAR
ACTIVATED PROTEIN C RESISTANCE APC
ADAMTS-13 PROFILE ADAMTS
ANTI-PHOSPHOLIPID ANTIBODY PANEL APHSA2
ANTI-THROMBIN III PLASMA AT3
BETA-2 GLYCOPROTEIN 1 B2GP1
CARDIOLIPIN ANTIBODY, IGG AND IGM, SERUM ACA
D-DIMER (ELISA) DDIML
D-DIMER PLASMA, QUALITATIVE DDIM
DILUTE RUSSELL VIPER VENOM DRVVTP
EUGLOBULIN CLOT LYSIS ECL
FACTOR II ASSAY FACT2
FACTOR IX ASSAY FACT9
FACTOR V ASSAY FACT5
FACTOR VII ASSAY FACT7
FACTOR VIII ASSAY FACT8
FACTOR VIII INHIBITOR, HUMAN F8INH
FACTOR X ASSAY FACT10
FACTOR XI ASSAY FACT11
FACTOR XII ASSAY FACT12
FACTOR XIII SCREEN FACT13
FIBRIN DEGRADATION PRODUCTS FDP
FREE PROTEIN S ACTIVITY, PLASMA PROTSF
HEPARIN PLATELET FACTOR 4 ANTIBODY HITAB
HEPARIN X A (FONDAPARINUX), PLASMA ARIX
HIT FUNCTIONAL BY IMPEDANCE AGGREGOMETRY HITIA
LMWH ACTIVITY BY ANTI-Xa ACTIVITY ANTIXA
LUPUS ANTICOAGULANT - PTTLA LUPUS
PHOSPHATIDYLSERINE/PROTHROMBIN ANTIBODIES LABAPSPT
PLASMINOGEN ACTIVITY PLASMN
PLATELET AGGREGATION PLTAGG
PLATELET FUNCTION SCREEN PLTFUN
PLATELET INHIBITION BY THROMBOELASTOGRAPHY PLATELET MAPPING PLTMAP
PROTEIN C ANTIGEN, TOTAL TOTALC
PROTEIN C, ACTIVITY, PLASMA PROTC
PROTEIN S ANTIGEN, TOTAL TOTALS
PROTEIN S, ACTIVITY, PLASMA PROTS
PT INHIBITOR SCREEN PTINH
PTT INHIBITOR SCREEN PTTINH
REPTILASE TIME REPT
RISTOCETIN-INDUCED PLATELET AGGREGATION RIPA
THROMBIN TIME TT
VON WILLEBRAND DISEASE SCREEN VWSCN
VON WILLEBRAND FACTOR ACTIVITY VWACT
VON WILLEBRAND FACTOR ANTIGEN PLASMA VWAG

Back To Top

Flow Cytometry View Department Homepage

TESTS:
Select a test to view Test Description & Clinical Indications
TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions
CD34 PANEL, BLOOD CD34
CD34 PANEL, BONE MARROW BMCD34
CD34 PANEL, FLUID FCD34
CD4-CD8 PANEL, BLOOD C4C8
EMA (EOSIN-5-MALEIMIDE) BY FLOW CYTOMETRY EMA
IMMUNOPHENOTYPING BY FLOW CYTOMETRY FCPATH
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA SCREEN (PNH) SCREEN PATH13/FCPATH PATH13/FCPATH
SÉZARY/T-CELL PANEL PATH18
T SUBSETS AND B LYMPHS, FLUID FTBLYM
T SUBSETS AND B LYMPHS, WHOLE BLOOD TBLYM

Back To Top

Malignant Hematology Testing Program View Here

 
 


 
Home | About Stanford Clinical Laboratories | Careers | Contact Us | Legal Notices & Disclaimer